Summary of Purpose
The primary objectives of this study is to evaluate the efficacy of HLCM051 on functional outcome in subjects with acute ischemic stroke and to evaluate the safety of HLCM051 in subjects with acute ischemic stroke.Read More →
The following dates are available for this trial. Trial information last updated on 16 February 2018.
|15 Nov 2017||7 Nov 2016||1 Mar 2020||1 Dec 2020||1 Feb 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Kiyohiro Houkin, MD
email@example.com 81 011 706 5600